Home
About
Who We Are
Contact
Technology
The Centrose Advantage
EDC Technology
Cancer Treatment Needs
Publications
EDC Pipeline
The EDC
EDC9
EDC1
EDC8
Connecting
Join Us
Invest
Partner
Press

Centrose

Home
About
Who We Are
Contact
Technology
The Centrose Advantage
EDC Technology
Cancer Treatment Needs
Publications
EDC Pipeline
The EDC
EDC9
EDC1
EDC8
Connecting
Join Us
Invest
Partner
Press
shutterstock_48494548_cc04.jpg

Press

 

  • 1/26/2024 Centrose Granted EU3328393 Patent Protection for Proxalpha

  • 1/01/2020 | Original Article Discusses EDC9 Surfaceome Shows CD20 NKA Complex

  • 8/01/2017 |  Centrose Granted Japanese Patent Covering EDC Technology

  • 4/20/2017 | Centrose to Present at 2017 PEGS Summit in Boston

  • 02/01/2017 | Centrose to Present EDC9 Clinical Progress at 2017 AACR Meeting

  • 01/31/2017 | Original Article Discusses EDC1 Therapy for Thyroid Cancer

  • 11/07/2016 | Centrose to Present at 2016 World Precision Medicine Congress

  • 09/25/2016 | Centrose to Present at 2016 BIO Investor Forum

  • 08/25/2016 | Centrose to Present at 2016 World Summit on Precision Medicine

  • 07/25/2016 | Centrose EDC study published in Molecular Therapy

  • 06/01/2016 | Centrose to Present at 2016 IBC Bioconjugates Meeting

  • 04/15/2016 | Centrose to Present at 2016 Annual AACR Meeting in New Orleans

  • 09/03/2015 | Centrose to Present at 2015 AACR.NCI.EORTC Meeting in Boston

  • 05/01/2015 | Centrose to Present at Cavendish Global Forum

  • 04/14/2015 | Centrose to Present at the 2015 Annual AACR Meeting

  • 08/04/2014 | WSJ - A Centrose Update

  • 07/18/2014 | Centrose to Present Keynote in Boston

  • 05/15/2014 | NCI Funds EDC1 Renal Cancer Investigation

  • 04/22/2014 | Conjugated Steroid Patent Issues

  • 03/18/2014 | Centrose Moves into New Facility
Back to Top

Centrose, LLC.